C. RUSSELL TRENARY III

Insider Reports History

Location
Santa Ana, CA
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by C. RUSSELL TRENARY III:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. CEO AND PRESIDENT, Director Stock Option (Right to Buy) 455,000 20 Mar 2024 Direct

Insider Reports Filed by C. RUSSELL TRENARY III

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 20 Mar 2024 1 $0 4 CEO AND PRESIDENT, Director 22 Mar 2024, 17:00
OTLK Outlook Therapeutics, Inc. 17 Apr 2023 1 $0 4 CEO and President, Director 19 Apr 2023, 17:40
OTLK Outlook Therapeutics, Inc. 21 Jun 2022 1 +$21,120 4 CEO and President, Director 23 Jun 2022, 17:07
OTLK Outlook Therapeutics, Inc. 31 Mar 2022 1 $0 4 CEO and President, Director 04 Apr 2022, 18:44
OTLK Outlook Therapeutics, Inc. 06 Dec 2021 1 +$34,750 4 CEO and President, Director 06 Dec 2021, 16:27
OTLK Outlook Therapeutics, Inc. 02 Dec 2021 1 +$14,000 4 CEO and President, Director 02 Dec 2021, 16:07
OTLK Outlook Therapeutics, Inc. 06 Jul 2021 1 $0 4 CEO and President, Director 08 Jul 2021, 17:26
OTLK Outlook Therapeutics, Inc. 06 Jul 2021 0 $0 3 CEO and President, Director 08 Jul 2021, 17:24